MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-30-2026
Baxter International Retained Earnings 2011-2026 | BAX
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Baxter International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.7 B | 14.9 B | 16.1 B | 14 B | 17.1 B | 16.3 B | 15.7 B | 15.6 B | 14.5 B | 14.2 B | 9.68 B | 13.2 B | 11.9 B | 10.9 B | 9.43 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17.1 B | 9.43 B | 13.8 B |
Quarterly Retained Earnings Baxter International
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.7 B | 14.8 B | 15 B | 15 B | 15.5 B | 15.5 B | 16 B | 16 B | 13.7 B | 13.9 B | 14 B | 14 B | - | 17 B | 17.1 B | 17 B | 16.7 B | 16.5 B | 16.3 B | 16.3 B | 16.3 B | 16.3 B | 15.7 B | 15.7 B | 15.7 B | 15.7 B | 15.1 B | 15.1 B | 15.6 B | 15.6 B | 14.5 B | 14.5 B | 14.5 B | 14.5 B | 14.2 B | 14.2 B | 14.2 B | 14.2 B | 9.68 B | 9.68 B | 9.68 B | 9.68 B | 13.2 B | 13.2 B | 13.2 B | 13.2 B | 11.9 B | 11.9 B | 11.9 B | 11.9 B | 10.9 B | 10.9 B | 10.9 B | 10.9 B | 9.43 B | 9.43 B | 9.43 B | 9.43 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 17.1 B | 9.43 B | 13.8 B |
Retained Earnings of other stocks in the Medical instruments industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
382 K | - | - | $ 810 M |  USA |
 |
The Cooper Companies
COO
|
7.64 B | $ 61.75 | 0.49 % | $ 12.3 B | USA |
 |
Luminex Corporation
LMNX
|
83.8 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
-120 M | - | -9.52 % | $ 20.6 M | USA |
 |
ICU Medical
ICUI
|
691 M | $ 129.31 | 4.57 % | $ 3.19 B | USA |
 |
Alcon
ALC
|
19.4 B | $ 67.28 | 1.48 % | $ 40.4 B |  Schweiz |
 |
Intuitive Surgical
ISRG
|
7.01 B | $ 449.03 | 1.69 % | $ 160 B | USA |
 |
iRhythm Technologies
IRTC
|
-803 M | $ 117.0 | 2.78 % | $ 3.74 B | USA |
 |
Repro Med Systems
KRMD
|
-32 M | $ 4.0 | 1.01 % | $ 185 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
-223 M | - | - | $ 955 M | USA |
 |
LeMaitre Vascular
LMAT
|
185 M | $ 101.43 | 0.1 % | $ 2.3 B | USA |
 |
Cantel Medical Corp.
CMD
|
548 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
-11.9 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
2.13 B | - | -0.05 % | $ 10.3 B | USA |
 |
Masimo Corporation
MASI
|
1.49 B | $ 178.79 | -0.01 % | $ 9.53 B | USA |
 |
Milestone Scientific
MLSS
|
-134 M | $ 0.4 | 14.99 % | $ 32.8 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
-262 M | - | - | $ 28.6 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.13 B | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
-191 M | $ 6.13 | 3.81 % | $ 52 K | USA |
 |
Envista Holdings Corporation
NVST
|
-440 M | $ 23.77 | 3.15 % | $ 3.99 B | USA |
 |
Haemonetics Corporation
HAE
|
352 M | $ 59.56 | 4.79 % | $ 3 B | USA |
 |
STERIS plc
STE
|
2.48 B | $ 215.97 | 0.67 % | $ 21.3 B | USA |
 |
Isoray
ISR
|
-335 M | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
-599 M | $ 143.82 | 2.71 % | $ 6.97 B | USA |
 |
STAAR Surgical Company
STAA
|
-148 M | $ 33.05 | 1.38 % | $ 1.64 B | USA |
 |
InfuSystem Holdings
INFU
|
-60.7 M | $ 10.16 | 5.07 % | $ 210 M | USA |
 |
Microbot Medical
MBOT
|
-104 M | $ 1.74 | 0.58 % | $ 79.7 M |  Israel |
 |
Teleflex Incorporated
TFX
|
3.15 B | $ 135.18 | 1.81 % | $ 6.03 B | USA |
 |
Utah Medical Products
UTMD
|
129 M | $ 64.17 | 0.27 % | $ 208 M | USA |
 |
Merit Medical Systems
MMSI
|
824 M | $ 64.49 | 1.13 % | $ 3.82 B | USA |
 |
West Pharmaceutical Services
WST
|
4.37 B | $ 305.5 | 0.55 % | $ 22.1 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
-1.56 B | $ 9.84 | 1.03 % | $ 1.96 B | USA |
 |
Pulse Biosciences
PLSE
|
-463 M | $ 26.09 | 4.57 % | $ 1.76 B | USA |
 |
Retractable Technologies
RVP
|
13.9 M | $ 0.66 | -2.35 % | $ 19.8 M | USA |
 |
Pro-Dex
PDEX
|
35.9 M | $ 63.47 | 4.43 % | $ 209 M | USA |
 |
Predictive Oncology
POAI
|
-414 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
-340 M | $ 24.0 | 4.12 % | $ 1.15 B | USA |
 |
Stereotaxis
STXS
|
-583 M | $ 1.85 | 7.56 % | $ 168 M | USA |
 |
ResMed
RMD
|
3.61 B | $ 209.86 | 0.98 % | $ 30.7 B | USA |
 |
AtriCure
ATRC
|
-413 M | $ 29.0 | 0.69 % | $ 1.38 B | USA |
 |
Harvard Bioscience
HBIO
|
-215 M | $ 5.4 | 7.78 % | $ 240 M | USA |
 |
NeuroMetrix
NURO
|
-218 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
-429 M | $ 11.81 | 3.23 % | $ 482 M | USA |
 |
Becton, Dickinson and Company
BDX
|
16.6 B | $ 146.95 | 0.02 % | $ 42.3 B | USA |
 |
Nephros
NEPH
|
-143 M | $ 3.57 | -1.79 % | $ 37.9 M | USA |
 |
OraSure Technologies
OSUR
|
-172 M | $ 3.07 | -0.32 % | $ 226 M | USA |
 |
Repligen Corporation
RGEN
|
456 M | $ 111.74 | 2.97 % | $ 6.28 M | USA |